Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vacuolar-type H+-ATPase (V-ATPase) V0 domain is the membrane-embedded sector of a multi-subunit enzyme that functions as an ATP-driven proton pump [3, 10]. It is responsible for the translocation of protons across biological membranes, a process essential for acidifying intracellular organelles such as lysosomes, endosomes, and the Golgi apparatus [1, 11]. This acidification is critical for various cellular processes, including protein degradation, receptor recycling, and nutrient sensing via the mTORC1 pathway [4, 11]. In specialized cells like osteoclasts, the V0 domain is targeted to the plasma membrane to facilitate bone resorption, while in cancer cells, its overexpression promotes an acidic microenvironment that favors invasion, metastasis, and drug resistance [8, 16]. The V0 domain also plays a non-canonical role in membrane fusion by interacting with SNARE proteins [5]. Pharmacological inhibitors, such as bafilomycin A1 and archazolid, target the V0 c-subunit ring to block proton transport, making the V0 domain a significant therapeutic target for osteoporosis, viral infections, and oncology [8, 13]. However, the ubiquitous nature of V-ATPases presents challenges for achieving tissue-specific inhibition and avoiding systemic toxicity [9].
Inhibition of proton translocation by binding to the proteolipid c-subunit ring of the V0 domain, which prevents the rotation of the V0 sector relative to the V1 sector and disrupts the ATP-driven proton pumping mechanism [10, 13, 15].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar-type H+-ATPase V0 domain (V0 domain).